Meibomian gland dysfunction (MGD) is the leading cause of dry eye disease and can cause serious, chronic eyelid problems for patients if left untreated. The Thermal 1-Touch™ System uses application of localized heat therapy in adult patients with dry eye disease due to meibomian gland dysfunction (MGD) to aid in clearing the blocked glands.  Patented OCuSOFT® Thermal 1-Touch™ applies heat and gentle pressure to the eyelids for a specific period of time in order to liquefy meibum, an oily coating which naturally prevents tear film from evaporating. Once the lipid blockage is softened it can then be expressed by the doctor allowing the glands to function properly again.  Unlike the traditional warm compress, OCuSOFT® Thermal 1-Touch™ Digi-Lens™ technology is designed with precision to provide instant targeted heat with a temperature that remains constant. OCuSOFT® Thermal 1-Touch™ is intended for localized heat in-office for applications such as Meibomian Gland Dysfunction (MGD), Dry Eye, Blepharitis, Stye, or Chalazia. 

Many patients have decreased their dependence and frequency of use with lubricating drops. That being said, each meibomian gland is as unique as each patient, meaning the results of Thermal 1-Touch™ can vary patient-by-patient.

Studies have showed that Thermal 1-Touch™ System is well-tolerated and an effective procedure for patients, with effects lasting from 6 to 12 months. 

The Thermal 1-Touch™ System is not billable to your medical insurance and is an out-of-pocket expense.                            

The Thermal 1-Touch™ treatment has been performed on well over 10,000 patients in the United States. 

The Thermal 1-Touch™ treatment process:

  • The Thermal 1-Touch™ device is placed on your upper and lower eyelids, similar to wearing a pair of eyeglasses
  • Once the Thermal 1-Touch™ procedure starts, you will feel soothing, pulsating warmth being applied to your eyelids
  • This is followed by 10-30 minutes of gentle heating (depending on the temperature setting)
  • A tone will sound at the end of the heat cycle and the Thermal 1-Touch™ “eyeglass” device will be removed
  • The clinician will then instill numbing drops for your comfort and gently squeeze the lids to express the glands